Norman L. Halleen
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Siebert | M | 84 | 13 anni | |
| V. Lawlis | M | 72 | 5 anni | |
| Nancy E. Pecota | F | 64 | 10 anni | |
| Howard D. Palefsky | M | - |
Collagen Corp.
| 19 anni |
| Igor Gonda | M | 76 | 17 anni | |
| Richard P. Thompson | M | 72 | 11 anni | |
| David Kabakoff | M | 76 | 9 anni | |
| Stephen W. Kaldor | M | 62 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 anni |
| Nathaniel David | M | 56 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 4 anni |
| Deno G. Bokas | M | 61 | 1 anni | |
| Dennis Jeffery Grimes | M | 60 | 3 anni | |
| Leonid Beigelman | M | 66 | 4 anni | |
| William Hodder | M | - | 4 anni | |
| Gregory Flesher | M | 54 | 4 anni | |
| Mark R. Thompson | M | 71 | 1 anni | |
| Daniel P. Maher | M | - | 5 anni | |
| Peter D. Noymer | M | 57 | 7 anni | |
| Leslie Tari | M | 57 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 anni |
| Karen S. Wright | F | 69 | 2 anni | |
| Jennifer D. Haldeman | F | 59 | 1 anni | |
| Thomas Chesterman | M | 64 | 5 anni | |
| John R. Daniels | M | 85 |
Collagen Corp.
| 23 anni |
| William Halter | M | 63 | 4 anni | |
| David J. Foster | M | 66 |
Collagen Corp.
| 5 anni |
| Bobba Venkatadri | M | 79 | 3 anni | |
| Stephen Jaeger | M | 79 | 5 anni | |
| Timothy Patrick Lynch | M | 54 | 2 anni | |
| Tom R. Hodgson | M | 82 | - | |
| Richard B. Love | M | 62 | 3 anni | |
| Maximillian D. Fiore | M | 69 | 9 anni | |
| Jonathan Rigby | M | 56 | 4 anni | |
| Cynthia Y. Robinson | M | 65 | 3 anni | |
| John J. Turanin | M | 66 | 9 anni | |
| Michael Molkentin | M | 69 | 2 anni | |
| Roger L. Hawley | M | 71 | 3 anni | |
| Jun Yoon | M | 46 |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 36 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Norman L. Halleen
- Contatti personali
